MSH2 and cancer: However, it is notable that the most clinically predictive datasets were all for cancer‐related genes (P53, BRCA1, PTEN and MSH2 as tumour suppressors and HRAS as a proto‐oncogene), all of which except MSH2 also have relatively high correlations with VEP predictions.